using talen gene editing to improve the efficacy of t-cell therapies
Published 2 years ago • 173 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:44
developing autologous t-cell therapies with crispr-cas technology
-
1:38
genome editing tools in t cell-based immunotherapies
-
1:18
autologous gene editing using the crispr system to treat primary immunodeficiency disorders
-
2:34
the potential of gene-edited effector cell therapy
-
1:02
the use of car-t cell products in a real-world setting
-
21:38
drawing the line: the rationale behind blood tube collection order
-
3:54
germline editing is not safe, not needed & unethical | doha debate: future of genetics
-
4:08
gene silencing techniques | crispr vs talen vs zfn | genome editing methods | differences
-
3:57
targeting t-cell malignancies with crispr/cas9 gene edited universal car-t
-
1:01
advancements in gene editing for scd: reni-cel and base editing platforms
-
3:37
progress in the categorization and treatment of lr-mds
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:12
an update in cellular therapies: gene editing for scd and immunotherapies for mm
-
3:27
the mechanism of bispecific t-cell engagers in b-all: genomic alterations
-
56:11
esgct e-seminar: virus-free gene editing of t cells
-
0:43
developing an avidcar platform to improve t-cell activity
-
1:52
exploring the possibility of treating scd in-utero with novel gene-editing technology
-
3:24
overview of talen gene editing and its use in treating hematologic cancers
-
2:57
genome characterization of t-all patients
-
3:04
tcr gene editing in cancer therapy
-
0:42
the importance of genomic characterization in t-all
-
25:36
professor waseem qasim - talen, crispr and base edited car t-cells for all